ArticleJournal of synchrotron radiation2025
Present and future structural biology activities at DESY and the European XFEL.
Article in Journal of synchrotron radiation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Orchestrating agentic systems at ALS beamline 5.3.1 with Osprey and Bluesky.Journal of synchrotron radiation · 2026Article
- Synchrotron structural biology at SSRL, the beginning and beyond.Journal of synchrotron radiation · 2026Article
- 50th anniversary of the Stanford SSRL synchrotron radiation and protein crystallography initiative.Journal of synchrotron radiation · 2026Article
- Identification, validation, and characterization of approved and investigational drugs interfering with the SARS-CoV-2 endoribonuclease Nsp15.Protein science : a publication of the Protein Society · 2025Article
- Present and future structural biology activities at DESY and the European XFEL. Erratum.Journal of synchrotron radiation · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Structural biology investigations using synchrotron radiation have a long history at the photon science facilities at DESY. Presently, EMBL and DESY operate state-of-the-art macromolecular crystallography and biological SAXS stations at the synchrotron radiation source PETRA III for the international user community. New experimental opportunities for experiments with femtosecond temporal resolution and for extremely small macromolecular crystals have become available with the advent of X-ray free-electron lasers (XFELs) such as the European XFEL. Within large international collaborations, groups at DESY and the European XFEL have contributed significantly to the development of experimental and data analysis methods to enable serial crystallography experiments at both XFELs and high-brilliance synchrotron radiation sources. The available portfolio of analytical infrastructure in photon science at DESY has attracted several campus partners to contribute to the development of instruments and methods and provide their own complementary experimental techniques, thereby establishing a fruitful scientific environment to make significant contributions to present and future societal challenges in the field of life sciences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.